In 19/100(19%) breast cancer samples tested, TWIST1 was overexpressed, while in 15/100(15%) samples the CD24−/low/CD44high profile, and in 9/100(9%) the CD24−/low/ALDH1high profile was detected (Figure 2A). Here, TWIST1 is linked to breast cancer.